148 related articles for article (PubMed ID: 8955659)
1. Prediction of colorectal cancer relapse and survival via tissue RNA levels of matrix metalloproteinase-9.
Zeng ZS; Huang Y; Cohen AM; Guillem JG
J Clin Oncol; 1996 Dec; 14(12):3133-40. PubMed ID: 8955659
[TBL] [Abstract][Full Text] [Related]
2. Association of ets-related transcriptional factor E1AF expression with tumour progression and overexpression of MMP-1 and matrilysin in human colorectal cancer.
Horiuchi S; Yamamoto H; Min Y; Adachi Y; Itoh F; Imai K
J Pathol; 2003 Aug; 200(5):568-76. PubMed ID: 12898592
[TBL] [Abstract][Full Text] [Related]
3. Colocalisation of matrix metalloproteinase-9-mRNA and protein in human colorectal cancer stromal cells.
Zeng ZS; Guillem JG
Br J Cancer; 1996 Oct; 74(8):1161-7. PubMed ID: 8883399
[TBL] [Abstract][Full Text] [Related]
4. Elevated tissue inhibitor of metalloproteinase 1 RNA in colorectal cancer stroma correlates with lymph node and distant metastases.
Zeng ZS; Cohen AM; Zhang ZF; Stetler-Stevenson W; Guillem JG
Clin Cancer Res; 1995 Aug; 1(8):899-906. PubMed ID: 9816060
[TBL] [Abstract][Full Text] [Related]
5. Limited value of preoperative serum analyses of matrix metalloproteinases (MMP-2, MMP-9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, TIMP-2) in colorectal cancer.
Oberg A; Höyhtyä M; Tavelin B; Stenling R; Lindmark G
Anticancer Res; 2000; 20(2B):1085-91. PubMed ID: 10810401
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloprotease 2 (MMP-2) and matrix metalloprotease 9 (MMP-9) type IV collagenases in colorectal cancer.
Liabakk NB; Talbot I; Smith RA; Wilkinson K; Balkwill F
Cancer Res; 1996 Jan; 56(1):190-6. PubMed ID: 8548762
[TBL] [Abstract][Full Text] [Related]
7. Clinical relevance of the expression of mRNA of MMP-7, MMP-9, TIMP-1, TIMP-2 and CEA tissue samples from colorectal liver metastases.
Sutnar A; Pesta M; Liska V; Treska V; Skalicky T; Kormunda S; Topolcan O; Cerny R; Holubec L
Tumour Biol; 2007; 28(5):247-52. PubMed ID: 17992052
[TBL] [Abstract][Full Text] [Related]
8. Expression of CD147 and matrix metalloproteinase-11 in colorectal cancer and their relationship to clinicopathological features.
Tian X; Ye C; Yang Y; Guan X; Dong B; Zhao M; Hao C
J Transl Med; 2015 Oct; 13():337. PubMed ID: 26507719
[TBL] [Abstract][Full Text] [Related]
9. High expression of matrix metalloproteinases: MMP-2 and MMP-9 predicts poor survival outcome in colorectal carcinoma.
Salem N; Kamal I; Al-Maghrabi J; Abuzenadah A; Peer-Zada AA; Qari Y; Al-Ahwal M; Al-Qahtani M; Buhmeida A
Future Oncol; 2016 Feb; 12(3):323-31. PubMed ID: 26814712
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
Ries C; Loher F; Zang C; Ismair MG; Petrides PE
Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746
[TBL] [Abstract][Full Text] [Related]
11. Prognostic and diagnostic implications of MMP-2, MMP-9, and VEGF-α expressions in colorectal cancer.
Araújo RF; Lira GA; Vilaça JA; Guedes HG; Leitão MC; Lucena HF; Ramos CC
Pathol Res Pract; 2015 Jan; 211(1):71-7. PubMed ID: 25446246
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of Reg4, alone or combined with MMP-7 overexpression, is predictive of poor prognosis in colorectal cancer.
Zhu X; Han Y; Yuan C; Tu W; Qiu G; Lu S; Lu H; Peng Z; Zhou C
Oncol Rep; 2015 Jan; 33(1):320-8. PubMed ID: 25338725
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological significance and prognostic value of MMP-13 expression in colorectal cancer.
Yang B; Gao J; Rao Z; Shen Q
Scand J Clin Lab Invest; 2012 Oct; 72(6):501-5. PubMed ID: 22950625
[TBL] [Abstract][Full Text] [Related]
14. Expression and prognostic value of matrix metalloproteinase-7 in colorectal cancer.
Yang B; Su K; Gao J; Rao Z
Asian Pac J Cancer Prev; 2012; 13(3):1049-52. PubMed ID: 22631636
[TBL] [Abstract][Full Text] [Related]
15. Association between ratio of matrix metalloproteinase-1 to tissue inhibitor of metalloproteinase-1 and local recurrence, metastasis, and survival in human chondrosarcoma.
Berend KR; Toth AP; Harrelson JM; Layfield LJ; Hey LA; Scully SP
J Bone Joint Surg Am; 1998 Jan; 80(1):11-7. PubMed ID: 9469303
[TBL] [Abstract][Full Text] [Related]
16. Prognostic values of matrix metalloproteinase family expression in human colorectal carcinoma.
Asano T; Tada M; Cheng S; Takemoto N; Kuramae T; Abe M; Takahashi O; Miyamoto M; Hamada J; Moriuchi T; Kondo S
J Surg Res; 2008 May; 146(1):32-42. PubMed ID: 17543340
[TBL] [Abstract][Full Text] [Related]
17. Role of tissue inhibitors of metalloproteinases (TIMPs) in colorectal carcinoma.
Joo YE; Seo KS; Kim J; Kim HS; Rew JS; Park CS; Kim SJ
J Korean Med Sci; 1999 Aug; 14(4):417-23. PubMed ID: 10485622
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer.
Iinuma H; Watanabe T; Mimori K; Adachi M; Hayashi N; Tamura J; Matsuda K; Fukushima R; Okinaga K; Sasako M; Mori M
J Clin Oncol; 2011 Apr; 29(12):1547-55. PubMed ID: 21422427
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous determination of matrix metalloproteinase (MMP)-7, MMP-1, -3, and -13 gene expression by multiplex PCR in colorectal carcinomas.
Roeb E; Arndt M; Jansen B; Schumpelick V; Matern S
Int J Colorectal Dis; 2004 Nov; 19(6):518-24. PubMed ID: 15103490
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of microRNA-21 as a biomarker in each Dukes' stage of colorectal cancer.
Fukushima Y; Iinuma H; Tsukamoto M; Matsuda K; Hashiguchi Y
Oncol Rep; 2015 Feb; 33(2):573-82. PubMed ID: 25421755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]